JUL 13, 2016 9:00 AM PDT

Tendon, Heal Thyself!

New TSRI Study Reveals Gene Crucial in Keeping Tendons Healthy

LA JOLLA, CA – July 13, 2016 – With the Rio Olympics just weeks away, many are wondering how Jamaican sprinter Usain Bolt will perform. Bolt is the fastest runner ever timed, but he’s also been nursing a tendon injury—the kind of injury that can take years to heal.

Why are tendon injuries—which also plague Kobe Bryant and Serena Williams, among many others—so tough to treat? Scientists at The Scripps Research Institute (TSRI) are working to answer that question by investigating how tendons develop and stay healthy in the first place.

“If we understand the molecular mechanisms of tendon development, we can apply the findings to develop a new regenerative therapy for tendon diseases and injuries,” said Hiroshi Asahara, a professor of molecular and experimental medicine at TSRI with joint appointments at Tokyo Medical and Dental University and the Japan Science and Technology Agency.

Now a new study from Asahara and his colleagues reveals the role of a gene called Mkx in maintaining and strengthening tendons in animal models. This gene also appears to prevent a debilitating tendon condition called “ossification.”

The findings, published as the cover article in the July 12 edition of the journal Proceedings of the National Academy of Sciences (PNAS), may bring doctors closer to one day using gene therapies to grow and repair tendons.
 

CRISPR/Cas9 Leads to Better Tendon Models


The new research built on previous studies showing that Mkx codes for a “transcription factor” called Mohawk (MKX), which tells cells to differentiate into tendon tissues when an embryo is first forming in utero.

Once formed, tendons end up with just a small sprinkling of cells among tight bundles of collagen and elastin fibers. These fibers make tendons flexible and strong, but the lack of cells—which produce the proteins needed for regeneration—makes injuries slow to heal.

In the new study, Asahara and his team wanted to study the possible role of Mkx in adult animals. They used a relatively new gene-editing system, called CRISPR/Cas9, to disable (“knock out”) Mkx in rat models. Creating knockouts was a significant advance in itself because rat embryonic stem cells are notoriously difficult to manipulate for these types of studies.
 

Gene Provides Life-Long Tendon Maintenance


The researchers then looked at Mkx to see if it was expressed in embryonic and adult rats. It was, suggesting that the gene indeed has a role later in life.

In fact, the researchers found that Mkx appears to be critical for sensing mechanical stress in tendons through adulthood. The MKX transcription factor appears to respond to stretching in the tendon by forming more tenocytes, the cells needed to maintain tendon fibers. In this way, MKX keeps tendons strong.

MKX also seems to prevent tendon cells from accidentally differentiating into cartilage or bone cells. The development of bone cells in the Achilles tendons and the cervical ligaments, called ossification, causes serious clinical problems, but the molecular mechanisms behind the phenomenon were previously unclear.

“Our findings should help to understand the pathogenesis of this disease and provide therapeutic clues,” said Asahara.

The researchers believe that future gene therapies could target Mkx to strengthen tendons. Asahara also highlighted the potential for using CRISPR/Cas9 in further studies of rats and larger animals, providing a new window into physiology.

In addition to Asahara, authors of the study, “Gene targeting of the transcription factor Mohawk in rats causes heterotopic ossification of Achilles tendon via failed tenogenesis,” were Hidetsugu Suzuki, Yoshiaki Ito, Satoshi Yamashita, Shizuko Ichinose, Akio Kishida, Takuya Oyaizu, Tomohiro Kayama, Ryo Nakamichi, Naoki Koda, Kazuyoshi Yagishita and Atsushi Okawa of Tokyo Medical and Dental University; Martin K. Lotz of the Japan Science and Technology Agency and Masahiro Shinohara of Tokyo Medical and Dental University and the Japan Science and Technology Agency.

This article was originally published on Scripps.edu.
About the Author
  • The Scripps Research Institute (TSRI) is one of the world's largest independent, not-for-profit organizations focusing on research in the biomedical sciences. TSRI is internationally recognized for its contributions to science and health, including its role in laying the foundation for new treatments for cancer, rheumatoid arthritis, hemophilia, and other diseases. An institution that evolved from the Scripps Metabolic Clinic founded by philanthropist Ellen Browning Scripps in 1924, the institute now employs about 2,700 people on its campuses in La Jolla, CA, and Jupiter, FL, where its renowned scientists-including two Nobel laureates-work toward their next discoveries. The institute's graduate program, which awards PhD degrees in biology and chemistry, ranks among the top ten of its kind in the nation. For more information, see www.scripps.edu.
You May Also Like
DEC 22, 2020
Immunology
Is Too Much Tofu Elevating Your COVID Risk?
DEC 22, 2020
Is Too Much Tofu Elevating Your COVID Risk?
A study by researchers at the University of Michigan has found that high levels of cadmium — a heavy metal found i ...
DEC 20, 2020
Microbiology
How Do mRNA Vaccines Work?
DEC 20, 2020
How Do mRNA Vaccines Work?
Scientist Katalin Karikó studied mRNA vaccines for years. She spent years getting grant rejections, but has now helped c ...
DEC 21, 2020
Cell & Molecular Biology
Mutagens May Be Having a Bigger Effect Than We Knew
DEC 21, 2020
Mutagens May Be Having a Bigger Effect Than We Knew
New research has suggested that our DNA is more susceptible to mutagenic influences than we've appreciated. While organi ...
DEC 23, 2020
Immunology
COVID Survivors Stay Immune for at Least a Year
DEC 23, 2020
COVID Survivors Stay Immune for at Least a Year
Once the coronavirus enters the body, the immune system springs into action, producing antibodies that bind to and neutr ...
DEC 27, 2020
Drug Discovery & Development
Attacking Mitochondria in Tumors
DEC 27, 2020
Attacking Mitochondria in Tumors
Researchers found that attacking a cell’s mitochondria can starve cancer cells. The study involves a possible ther ...
JAN 06, 2021
Immunology
Probiotic Boosters Are Lifesavers for Preterm Babies
JAN 06, 2021
Probiotic Boosters Are Lifesavers for Preterm Babies
When administered shortly after birth, a recent study has found that the supplementation combo of probiotics and prebiot ...
Loading Comments...